Repligen Corp
(RGEN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | AZN | AMGN | GILD | BMY |
| Company | Repligen Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 142.11 | 200.08 | 365.14 | 148.90 | 60.60 |
| High | 145.43 | 204.76 | 368.51 | 156.97 | 61.08 |
| Low | 137.41 | 199.19 | 361.00 | 147.38 | 59.66 |
| Latest | 139.51 | 204.10 | 364.19 | 156.87 | 60.16 |
| Change | -3.55 | +10.70 | -0.46 | +9.64 | -0.70 |
| % Change | -2.48% | +5.53% | -0.13% | +6.55% | -1.15% |
| Volume | 296,852 | 2,053,213 | 1,544,327 | 7,298,671 | 5,428,582 |
| 20-Day Average Volume | 686,087 | 4,595,557 | 3,120,480 | 8,432,425 | 13,361,052 |
| Previous Close | 143.06 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 154.88 | 188.09 | 349.52 | 139.02 | 56.72 |
| 20-Day Raw Stochastic | 5.72% | 99.76% | 67.37% | 99.11% | 80.07% |
| 20-Day Relative Strength | 34.00 | 64.46 | 59.82 | 73.58 | 66.20 |
| Weighted Alpha | -3.40 | +47.14 | +31.30 | +62.09 | +23.26 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.46% since 02/04/26 | +8.57% since 02/04/26 | -0.48% since 02/04/26 | +7.13% since 02/04/26 | +4.75% since 02/04/26 |
| Low | 137.46 on 02/11/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 145.87 on 02/05/26 | 58.00 on 02/05/26 |
| High | 147.16 on 02/05/26 | 203.58 on 02/11/26 | 385.12 on 02/06/26 | 156.97 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -16.32% since 01/09/26 | +7.51% since 01/09/26 | +11.75% since 01/09/26 | +29.36% since 01/09/26 | +8.05% since 01/09/26 |
| Low | 137.46 on 02/11/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 174.87 on 01/22/26 | 203.58 on 02/11/26 | 385.12 on 02/06/26 | 156.97 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -9.02% since 11/11/25 | +14.22% since 11/11/25 | +7.68% since 11/11/25 | +27.81% since 11/11/25 | +23.88% since 11/11/25 |
| Low | 137.46 on 02/11/26 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 175.77 on 01/06/26 | 203.58 on 02/11/26 | 385.12 on 02/06/26 | 156.97 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +24.78% since 08/11/25 | +37.38% since 08/11/25 | +27.83% since 08/11/25 | +30.03% since 08/11/25 | +31.41% since 08/11/25 |
| Low | 111.48 on 08/12/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 175.77 on 01/06/26 | 203.58 on 02/11/26 | 385.12 on 02/06/26 | 156.97 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,052,991 | 299,945,568 | 196,357,104 | 182,665,312 | 123,895,928 |
| Shares Outstanding, K | 56,291 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 634,440,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -25,510,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 188,810,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 14,910,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 1.13 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.46 on 10/28/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/19/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 86.49 | 20.57 | 17.20 | 18.52 | 9.88 |